title: [Analysis of follow-up and administration of HIV-infected Burmese in Dehong prefecture of Yunnan province].
abstract: OBJECTIVE
  To compare follow-up and administration of HIV-infected local Chinese and Burmese in Dehong prefecture of Yunnan province, for scientific development of prevention and control measures.
  
  
  METHODS
  14 270 HIV-infected local Chinese and 5 436 HIV-infected Burmese reported from 1989 to December 31, 2013 in Dehong prefecture were recruited as the subjects of study, comparing the differences of follow-up and management, CD4⁺ T lymphocyte count tests and antiretroviral therapy (ART) between the two groups.
  
  
  RESULTS
  The proportion of HIV-infected Burmese identified in Dehong prefecture was 27.6% (5 436/19 706) during 1989-2013. The number had been growing rapidly from 17.1% in 1989-2003, 12.4% in 2004 and 14.7% in 2005 to over 51.4% in 2012, hitting 59.4% in 2013 (trends χ² = 1 732.84, P < 0.000 1). The proportion of HIV-infected Burmese among case reports of various characteristics kept rising over the years. By the end of 2013, 8 095 HIV-infected local Dehong residents and 5 326 HIV-infected Burmese were still alive. 95.8% of them were under follow-up, 88.5% having CD4⁺ T lymphocyte count tests, and 78.3% under ART. Among the HIV-infected B urmese, only 19.2% of them were under follow-up, 13.0% having CD4⁺ T lymphocyte count tests, and 6.1% under ART, significantly lower than the local Dehong residents (P < 0.000 1).
  
  
  CONCLUSIONS
  The proportion of follow-up and administration, CD4⁺ T lymphocyte count tests, and ART of HIV-infected Burmese was low in Dehong prefecture, Yunnan province, which called for more effective follow-up and administration measures.
authors.affiliation: Dehong Prefecture Center for Disease Control and Prevention, Dehong 678400, China.
authors.forename: Shijiang
authors.initials: S
authors.lastname: Yang
authors.affiliation: Dehong Prefecture Center for Disease Control and Prevention, Dehong 678400, China.
authors.forename: Yuecheng
authors.initials: Y
authors.lastname: Yang
authors.affiliation: Dehong Prefecture Center for Disease Control and Prevention, Dehong 678400, China.
authors.forename: Runhua
authors.initials: R
authors.lastname: Ye
authors.affiliation: Dehong Prefecture Center for Disease Control and Prevention, Dehong 678400, China.
authors.forename: Lifen
authors.initials: L
authors.lastname: Xiang
authors.affiliation: Dehong Prefecture Center for Disease Control and Prevention, Dehong 678400, China.
authors.forename: Yanfen
authors.initials: Y
authors.lastname: Cao
authors.affiliation: Dehong Prefecture Center for Disease Control and Prevention, Dehong 678400, China.
authors.forename: Renhai
authors.initials: R
authors.lastname: Tang
authors.affiliation: Dehong Prefecture Center for Disease Control and Prevention, Dehong 678400, China.
authors.forename: Jie
authors.initials: J
authors.lastname: Gao
authors.affiliation: Dehong Prefecture Center for Disease Control and Prevention, Dehong 678400, China.
authors.forename: Jibao
authors.initials: J
authors.lastname: Wang
authors.affiliation: Dehong Prefecture Center for Disease Control and Prevention, Dehong 678400, China.
authors.forename: Baosen
authors.initials: B
authors.lastname: Zhang
authors.affiliation: Dehong Prefecture Center for Disease Control and Prevention, Dehong 678400, China; Email: dhduansong@sina.com.cn.
authors.forename: Song
authors.initials: S
authors.lastname: Duan
authors.affiliation: Department of Epidemiology, School of Public Health, Key Laboratory of Public Health Safety, Ministry of Education, Fudan University; Email: nhe@shmu.edu.cn.
authors.forename: Na
authors.initials: N
authors.lastname: He
mesh_terms: D019380:Anti-HIV Agents / Q000627:therapeutic use*; D044466:Asian People; D018791:CD4 Lymphocyte Count; D002681:China; D005500:Follow-Up Studies; D015658:HIV Infections / Q000188:drug therapy* / Q000276:immunology; D006801:Humans
chemical_list: D019380:Anti-HIV Agents